Nine Point Two Capital LLC Relay Therapeutics, Inc. Transaction History

Nine Point Two Capital LLC

  • $252 Million
  • Q4 2023

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 14, 2023
BUY
$9.99 - $18.27 $228,840 - $418,510
22,907 New
22,907 $287,000
Q4 2022

Feb 14, 2023
BUY
$14.16 - $24.02 $204,045 - $346,128
14,410 New
14,410 $215,000
Q2 2022

Aug 15, 2022
SELL
$13.31 - $34.88 $235,187 - $616,329
-17,670 Closed
0 $0
Q1 2022

May 16, 2022
BUY
$20.26 - $32.36 $357,994 - $571,801
17,670 New
17,670 $528,000

Others Institutions Holding RLAY

# of Institutions
206
Shares Held
156M
Call Options Held
207K
Put Options Held
40K
View Full List

About Relay Therapeutics, Inc.

RLAY Quotes by TradingView
  • Ticker RLAY
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 120,219,000
  • Market Cap $583M
  • Description
  • Relay Therapeutics, Inc. operates as a clinical-stage precision medicines company. It engages in transforming the drug discovery process with an initial focus on enhancing small molecule therapeutic discovery in targeted oncology and genetic disease indications. The company's lead product candidates include RLY-4008, an oral small molecule inhib...
More about RLAY
Track This Portfolio

Track Nine Point Two Capital LLC Portfolio

Follow Nine Point Two Capital LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Nine Point Two Capital LLC, based on Form 13F filings with the SEC.

News

Stay updated on Nine Point Two Capital LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email